1 A nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. 2  Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear.
Bravecto (fluralaner) is a systemic antiparasitic drug introduced to the veterinary market by Merck in 2014. A 7 March 2014 study published in the journal Parasites & Vectors (based upon a study of 32 beagles treated with fluralaner) observed no serious adverse side effects attributed to the medication:
Bravecto is the first oral flea and tick medication that lasts for up to 12 weeks. Bravecto kills fleas, as well as black-legged ticks (also called deer ticks), American dog ticks, and brown dog ticks, for 12 weeks following a single dose. It is also effective against the Lone Star tick for 8 weeks.